Figure GPS-33 Overview of drug prevalence estimates from various studies in Europe for all adults (aged 15 to 64) and young adults (aged 15 to 34) – Part (ii) Cocaine, amphetamines and ecstasy use – lifetime experience, recent use (last 12 months) and current use (last 30 days)

Figure GPS-33 part ii

Notes:

For details of the studies included see Tables GPS-1 to GPS-6.

The chart shows the overall average of the relevant studies, weighted by sample size. 

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Reitox national reports (2005), taken from population surveys, reports or scientific articles.

See also Table GPS-0.